Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a gentle brain zap boost memory in dementia?

NCT ID NCT05326750

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 37 times

Summary

This study tests whether a gentle, non-invasive brain stimulation technique called tACS can improve memory and thinking in people with Alzheimer's disease, Lewy body dementia, frontotemporal dementia, and normal pressure hydrocephalus. Two hundred participants will receive either real or sham stimulation over four sessions. Researchers will measure changes in memory, orientation, and other cognitive tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kuopio University Hospital

    RECRUITING

    Kuopio, Finland

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

gamma transcranial alternating current stimulation (tACS) device

What this could lead to

If it works, this could offer a non-drug way to temporarily boost memory and thinking in people with common dementias.

What could go wrong

This is an early-stage study with only a single session of stimulation, so any benefits may be small or short-lived. The results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

Alzheimer disease frontotemporal dementia Lewy body dementia Lewy Body Disease normal pressure hydrocephalus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.